Research map: Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta‐Blockers: A Multi‐Institutional Cohort Study

Back to the article

Papers in this map

  1. Expanding consensus in portal hypertension · Roberto de Franchis · 2015 · 3100 citations · Cited by this paper
  2. Endoscopic Band Ligation as an Unmeasured Confounder in the Beta‐Blocker– PVT Association · Ji Feng · 2026 · Cites this paper
  3. Enhanced Liver Fibrosis Test, FIB ‐4 and FibroScan : Real‐World Prognostic Accuracy for MASLD in a Biopsy‐Controlled Cohort · 2026 · Related
  4. Baveno VII – Renewing consensus in portal hypertension · Roberto de Franchis · 2021 · 2898 citations · Cited by this paper
  5. Threshold‐Defined Liver Stiffness Trajectories and Liver‐Related Event Risk in Chronic Liver Disease: A Cohort Study · 2026 · Related
  6. The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule · Yasuko Iwakiri · 2006 · 618 citations · Cited by this paper
  7. Lactulose for Preventing Overt Hepatic Encephalopathy: Between Evidence and Unresolved Questions · 2026 · Related
  8. Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡ · Thomas Sersté · 2010 · 530 citations · Cited by this paper
  9. Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis · 2026 · Related
  10. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis · David Edward Kaplan · 2023 · 474 citations · Cited by this paper
  11. Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy · 2026 · Related
  12. Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis · Mattias Mandorfer · 2014 · 377 citations · Cited by this paper
  13. Microtubule‐Targeting Drugs Induce Mesenchymal–Epithelial Transition in Hepatic Stellate Cells · 2026 · Related
  14. Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized Trial · Gin‐Ho Lo · 2000 · 277 citations · Cited by this paper
  15. Burden and Regional Disparities of MASH ‐Related Liver Cancer in the Asia‐Pacific Region From 1990 to 2023 · 2026 · Related
  16. Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis · Rafael Bañares · 1999 · 194 citations · Cited by this paper
  17. High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan · 2026 · Related
  18. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis · Càndid Villanueva · 2022 · 187 citations · Cited by this paper
  19. Beta-blockers in cirrhosis: Evidence-based indications and limitations · Susana Rodrigues · 2019 · 173 citations · Cited by this paper
  20. Three Generations of β-blockers: History, Class Differences and Clinical Applicability · Gabriel Tavares do Vale · 2018 · 162 citations · Cited by this paper
  21. Systematic review with meta‐analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis · Emanuele Sinagra · 2014 · 148 citations · Cited by this paper
  22. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) · Thomas Reiberger · 2017 · 138 citations · Cited by this paper
  23. The changing role of beta-blocker therapy in patients with cirrhosis · Phillip S. Ge · 2013 · 135 citations · Cited by this paper
  24. Physiopathology of splanchnic vasodilation in portal hypertension · Maria Martell · 2010 · 132 citations · Cited by this paper
  25. Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices · Maja Sofie Thiele · 2012 · 103 citations · Cited by this paper
  26. TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research · Mahmoud Nassar · 2025 · 92 citations · Cited by this paper
  27. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem · Guadalupe García–Tsao · 2015 · 91 citations · Cited by this paper
  28. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma · Alberto Zanetto · 2018 · 79 citations · Cited by this paper
  29. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis · Xiangbo Xu · 2019 · 77 citations · Cited by this paper
  30. Screening and Surveillance of Varices in Patients With Cirrhosis · Simona Jakab · 2018 · 72 citations · Cited by this paper
  31. Nonselective beta‐blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study · Filipe Nery · 2019 · 68 citations · Cited by this paper
  32. Beta-blockers in the era of precision medicine in patients with cirrhosis · Agustı́n Albillos · 2022 · 61 citations · Cited by this paper
  33. Challenges Frequently Encountered in the Secondary Use of Electronic Medical Record Data for Research · Meghan E. Edmondson · 2020 · 46 citations · Cited by this paper
  34. Portal Vein Thrombosis in Cirrhosis · Akash Shukla · 2021 · 46 citations · Cited by this paper
  35. Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis · José Ignacio Fortea · 2024 · 31 citations · Cited by this paper
  36. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis · Xingshun Qi · 2014 · 29 citations · Cited by this paper
  37. Assessing the safety of beta‐blocker therapy in cirrhosis patients with ascites: A meta‐analysis · Robert J. Wong · 2019 · 25 citations · Cited by this paper
  38. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study · Xiangbo Xu · 2020 · 23 citations · Cited by this paper
  39. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients · Rosa Zampino · 2018 · 21 citations · Cited by this paper

Source: OpenAlex (CC0)